The Effect of Hepatic Impairment on the Pharmacokinetics of Balovaptan

Clinical trial NCT03912350 · WITHDRAWN

Trial details

NCT number: NCT03912350
Sponsor: Hoffmann-La Roche
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Autism Spectrum Disorder

Start date: 2022-06-26
Primary completion: 2022-09-24
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.